Nirsevimab in a single intramuscular dose prevents medically attended RSV infection and hospitalization in preterm infants
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "Nirsevimab in a Single Intramuscular Dose Prevents Medically Attended RSV Infection and Hospitalization in Preterm Infants." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315174/all/Nirsevimab_in_a_single_intramuscular_dose_prevents_medically_attended_RSV_infection_and_hospitalization_in_preterm_infants.
Nirsevimab in a single intramuscular dose prevents medically attended RSV infection and hospitalization in preterm infants. In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315174/all/Nirsevimab_in_a_single_intramuscular_dose_prevents_medically_attended_RSV_infection_and_hospitalization_in_preterm_infants. Accessed September 7, 2024.
Nirsevimab in a single intramuscular dose prevents medically attended RSV infection and hospitalization in preterm infants. (2019). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315174/all/Nirsevimab_in_a_single_intramuscular_dose_prevents_medically_attended_RSV_infection_and_hospitalization_in_preterm_infants
Nirsevimab in a Single Intramuscular Dose Prevents Medically Attended RSV Infection and Hospitalization in Preterm Infants [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2024 September 07]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315174/all/Nirsevimab_in_a_single_intramuscular_dose_prevents_medically_attended_RSV_infection_and_hospitalization_in_preterm_infants.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Nirsevimab in a single intramuscular dose prevents medically attended RSV infection and hospitalization in preterm infants
ID - 1315174
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315174/all/Nirsevimab_in_a_single_intramuscular_dose_prevents_medically_attended_RSV_infection_and_hospitalization_in_preterm_infants
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -